UnitedHealth Group Inc. buy UBS Group AG
Start price
19.07.24
/
50%
€519.00
Target price
19.07.25
€623.83
Performance (%)
-50.41%
Price
15.07.25
€251.40
This prediction will end soon
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG for UnitedHealth Group Inc. is performing very badly with a performance of -50.41%. Dividends of €5.98 are taken into consideration when calculating the performance. This prediction currently runs until 19.07.25. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
UnitedHealth Group Inc. | -4.192% | -4.192% |
iShares Core DAX® | -0.727% | 2.783% |
iShares Nasdaq 100 | 1.839% | 5.294% |
iShares Nikkei 225® | -2.033% | -0.196% |
iShares S&P 500 | 1.334% | 4.044% |
Comments by UBS_Group_AG for this prediction
In the thread UnitedHealth Group Inc. diskutieren
UnitedHealth Group Incorporated (NYSE: UNH) had its price target raised by analysts at UBS Group AG from $640.00 to $680.00. They now have a "buy" rating on the stock.
Ratings data for UNH provided by MarketBeat
Stopped prediction by UBS_Group_AG for UnitedHealth Group Inc.
UnitedHealth Group Inc.
Start price
Target price
Perf. (%)
€259.35
25.06.25
25.06.25
€331.06
25.06.26
25.06.26
-3.07%
15.07.25
15.07.25
UnitedHealth Group Inc.
Start price
Target price
Perf. (%)
€526.70
16.10.24
16.10.24
€597.87
16.10.25
16.10.25
-51.49%
15.07.25
15.07.25
UnitedHealth Group Inc.
Start price
Target price
Perf. (%)
€517.00
16.10.23
16.10.23
€606.91
16.10.24
16.10.24
1.97%
17.10.24
17.10.24